GLP-1 Savings Calculator — Compare Your Options
See exactly how much you could save by switching GLP-1 providers or payment methods. Enter what you currently pay, and we'll show every option side by side with your potential savings.
1. What are you currently paying?
Select a common scenario or enter a custom amount.
2. How long do you plan to be on treatment?
Longer durations amplify your savings.
3. Do you have insurance?
This affects which savings options are available to you.
How to Pay Less for GLP-1 Medications
1. Check your insurance formulary
Many commercial plans now cover Wegovy and Zepbound for weight management. Call the number on your insurance card and ask specifically about anti-obesity medication coverage. Even plans that denied coverage in 2024 may have updated their formularies for 2026.
2. Stack manufacturer savings cards
Novo Nordisk (Wegovy/Ozempic) and Eli Lilly (Zepbound/Mounjaro) both offer savings cards that can reduce your copay to $0-$25/mo with commercial insurance. These are free to apply for and can be used alongside your insurance benefits.
3. Consider compounded alternatives
Compounded semaglutide and tirzepatide use the same active ingredients as brand-name drugs but cost 80-90% less. Available through licensed telehealth platforms starting around $75-$160/mo without insurance. Quality varies by provider — stick to those using 503B-licensed pharmacies.
4. Wait for Medicare coverage (July 2026)
The Medicare GLP-1 Bridge program launches July 2026, offering transitional coverage at approximately $50/mo for Medicare beneficiaries. If you're on Medicare and can wait, this represents significant savings over current retail prices.
5. Compare telehealth providers
Prices vary dramatically between telehealth platforms — from $25/mo to $300/mo for similar medications. Use our comparison tools to find the best combination of price, clinical quality, and medication type for your situation.
Price Trends: GLP-1 Costs Are Dropping
GLP-1 medication prices have been falling steadily since late 2024. Eli Lilly launched Zepbound self-pay vials at $399/mo (later reduced further), Novo Nordisk responded with competitive pricing, and the compounded market has driven prices below $200/mo for many patients.
The biggest upcoming shift is Medicare coverage starting July 2026. The GLP-1 Bridge program will provide transitional coverage for Medicare beneficiaries at approximately $50/mo — a game changer for the 65+ population that has been largely priced out of these medications. Full Part D coverage for anti-obesity medications is expected to follow.
Competition is also increasing. Orforglipron (Eli Lilly's oral GLP-1) is now available as Foundayo, and several new GLP-1/GIP dual agonists are in late-stage trials. More options mean more pricing pressure — expect costs to continue declining through 2026 and 2027.
Frequently Asked Questions
What is the cheapest way to get GLP-1 medication?
How much does Wegovy cost without insurance?
Will Medicare cover GLP-1 medications in 2026?
Is compounded semaglutide as effective as Wegovy?
How can I save the most on GLP-1 medications?
Ready to find your best option?
Our match quiz considers your budget, insurance, medication preference, and priorities to recommend the right provider.
Disclaimer: Savings estimates are based on publicly available pricing from manufacturer programs (NovoCare, LillyDirect), Medicare GLP-1 Bridge program details, average telehealth platform pricing, and our provider database as of April 2026. Actual costs vary by insurance plan, pharmacy, location, and dosage. This tool is for informational purposes only and does not constitute financial or medical advice. Always verify pricing with your provider and insurance company before making treatment decisions.